Table 1 This table summarizes the key clinical and histopathological characteristics of the study population. In addition, it summarizes the surgical and therapeutic interventions that each patient had. The table is organized first according to the grade of the tumors and next according to the histological type of the tumor. OS - Overall Survival; DFS - Disease Free Survival; Size - tumor size in centimeters
From: 11-year experience with Chest Wall resection and reconstruction for primary Chest Wall sarcomas
Age | Sex | OS | DFS | Resection | Primary Dx | Size | Grade | Mode of Repair | Neoadjuvent | Adjuvent |
|---|---|---|---|---|---|---|---|---|---|---|
64 | Female | 10 | 3 | R1 | Angiosarcoma | 15 | High | GoreTex patch + musculocutaneous flap | Chemotherapy + Radiotherapy | |
16 | Male | 9 | 1 | R0 | Ewing sarcoma | 11 | High | GoreTex patch + primary repair | Chemotherapy | Chemotherapy + Radiotherapy |
10 | Female | 28 | 27 | R0 | Ewing sarcoma | 8 | High | GoreTex patch + primary repair | Chemotherapy | Chemotherapy + Radiotherapy |
31 | Male | 138 | 138 | R0 | Ewing sarcoma | 8 | High | GoreTex patch + primary repair | Chemotherapy | Chemotherapy + Radiotherapy |
12 | Female | 6 | 3 | R1 | Ewing sarcoma | 13 | High | GoreTex patch + primary repair | Chemotherapy | Chemotherapy + Radiotherapy |
5 | Male | 13 | 13 | R0 | Ewing sarcoma | 6 | High | Primary repair | Chemotherapy | Chemotherapy + Radiotherapy |
25 | Male | 10 | 10 | R0 | Ewing sarcoma | 20 | High | GoreTex patch + primary repair | Chemotherapy | Radiotherapy |
91 | Female | 9 | 7 | R1 | Pleomorphic sarcoma | 14 | High | Primary repair | Chemoterapy | |
67 | Female | 80 | 80 | R0 | Pleomorphic sarcoma | 9 | High | Musculocutaneous skin flaps | ||
66 | Male | 2 | 2 | R0 | Chondrosarcoma | 3 | Intermediate | Primary repair | ||
13 | Male | 27 | 27 | R0 | Synovial sarcoma | 3 | Intermediate | GoreTex patch + primary repair | ||
18 | Male | 52 | 52 | R0 | Synovial sarcoma | 5 | Intermediate | Primary repair | Chemotherapy | Radiotherapy |
66 | Male | 3 | 3 | R0 | Atypical ossifying fibromyxoid tumor | 9 | Low | Primary repair | ||
55 | Male | 33 | 33 | R0 | Chondrosarcoma | 6 | Low | GoreTex patch + primary repair | ||
57 | Male | 119 | 119 | R1 | Chondrosarcoma | 7 | Low | Primary repair | ||
64 | Male | 107 | 107 | R0 | Chondrosarcoma | 8 | Low | GoreTex patch + primary repair | ||
26a | Female | 123 | 55 | R1 | Desmoid | 10 | Low | Primary repair | Radiotherapy | |
R0 | Desmoid | 6 | Low | Primary repair | ||||||
25 | Male | 40 | 40 | R0 | Desmoid | 3 | Low | GoreTex patch + primary repair | ||
64 | Female | 48 | 41 | R1 | Desmoid | 5 | Low | GoreTex patch + primary repair | Tamoxifen | |
54 a | Male | 119 | 24 | R1 | Desmoid | 5 | Low | Primary repair | Radiotherapy | |
R1 | Desmoid | 6 | Low | Cutaneous skin flaps | Tamoxifen | |||||
20 a | Female | 135 | 20 | R0 | Desmoid | 7 | Low | Primary repair | ||
R0 | Desmoid | 4 | Low | Primary repair | ||||||
22 | Female | 105 | 105 | R0 | Epithelioid hemangioendothelioma | 7 | Low | Primary repair | ||
35 | Male | 33 | 33 | R0 | Fibromixoid sarcoma | 13 | Low | GoreTex patch + primary repair | Chemotherapy + Radiotherapy | |
69 | Male | 77 | 77 | R0 | Leiomyosarcoma | 6 | Low | Musculocutaneous skin flaps | ||
71 | Male | 9 | 9 | R1 | Liposarcoma | 21 | Low | Primary repair |